SodaMelt Official Website › Blog › Goldenseal And Your Prescription
Goldenseal And Your Prescription List: Working Out Whether It Matters
One row on this panel is worth a short conversation before the first capsule, and it is the eighth of eleven. Goldenseal inhibits two liver enzymes in people, those enzymes clear a large share of common prescriptions, and the carton says nothing about it. Here is how to find out in five minutes whether it concerns you.
- Goldenseal inhibits CYP3A4 and CYP2D6, measured in people rather than inferred from glassware.
- Those two enzymes handle a large share of commonly prescribed medicines between them.
- A national health information service reports metformin levels falling by around a quarter alongside goldenseal.
- The widely repeated P-glycoprotein claim was not supported by the human digoxin study.
- The amount in this blend is unknown, which is an argument for asking rather than for assuming it is too small to matter.
Why one row on a panel is worth a conversation
Most ingredients in a small botanical blend are present in amounts too low to do much of anything, which is the argument this website makes repeatedly about fibre, seeds and cultures on this same panel.
Interactions do not work like benefits. A benefit generally needs a threshold dose before anything happens. An enzyme inhibition is a competitive process, and competitive processes have no comparable floor: a small amount produces a small shift rather than no shift at all.
That asymmetry is the reason this article exists. The honest position on the psyllium row is that the amount is too small to matter. The honest position on the goldenseal row is that nobody can say, and that the cost of asking is a single conversation.
Two enzymes, and the share of medicines they handle
| Enzyme | Roughly what share of prescriptions it clears | Why that matters here |
|---|---|---|
| CYP3A4 | The largest single contributor to drug metabolism in people | Inhibiting it raises the level of whatever it was clearing |
| CYP2D6 | A substantial minority, including several common classes | Highly variable between people before any supplement is added |
| P-glycoprotein | A transporter rather than an enzyme | Widely claimed for goldenseal, and the human digoxin study did not support it |
Three mechanisms. The first two are supported in people for goldenseal; the third is the one repeated everywhere and not borne out by the human study.
Cytochrome P450 enzymes are the liver's main machinery for clearing foreign compounds, and two of them do a disproportionate amount of the work. CYP3A4 is the single largest contributor to drug metabolism in people. CYP2D6 handles a smaller but clinically important share, and its activity varies genetically between individuals before anything is added.
Inhibiting one of them does not make a medicine stop working. It makes it clear more slowly, which raises the level in the blood, which for most medicines means more effect and more side effect from the same tablet.
The alkaloids behind this are berberine and hydrastine, and reviews of goldenseal's alkaloid chemistry set out which compounds do what (a 2020 study of goldenseal's individual alkaloids).
What was actually measured in people
The distinction between a laboratory finding and a human one matters a great deal here, because a very large number of herb interaction claims exist only in glassware.
Goldenseal's does not. Controlled human studies found inhibition of both enzymes after goldenseal supplementation (a study of goldenseal and human cytochrome P450), and a probe study using midazolam, the standard CYP3A4 marker, measured the size of the effect directly (the goldenseal-midazolam interaction study).
More recent modelling work has taken those measurements and used them to predict the size of the effect on other medicines cleared by the same route (a pharmacokinetic modelling study). That is the modern shape of this field: measure the probe, model the rest.
Most of the herb interaction literature is in vitro, and most in vitro findings never reproduce in people at achievable doses. This one was measured in people, with a standard probe drug, and then modelled forward. That is about as good as this evidence gets.
Read the whole SodaMelt panel before the first capsule
Twelve names, one weight order, and the three interactions the carton does not mention. The window is 60 days from the purchase date.
One bottle $89 · six bottles $294 · 60-day money-back guarantee
Order SodaMelt On The Official WebsiteOne capsule a day · 30 per bottle · lot SOD-26/MY-2226
The claim that keeps getting repeated
Search for goldenseal interactions and you will find P-glycoprotein inhibition asserted almost everywhere. P-glycoprotein is a transporter that pumps compounds back out of cells, and inhibiting it would raise levels of the drugs it handles.
The human study that tested it used digoxin, the classic P-glycoprotein substrate, and found no significant effect (a human digoxin study that found no effect).
That finding is worth knowing for two reasons. It corrects a specific claim you will encounter repeatedly. And it makes the CYP findings more credible rather than less: a research group willing to publish a negative result on one mechanism is a group whose positive result on another is worth more.
The metformin figure, and what a quarter means
A national health information service reports that goldenseal taken alongside metformin lowered metformin levels by about 25 per cent (NCCIH).
A quarter is not a dramatic number and it is not a trivial one either. For a medicine being titrated to an effect, a quarter less in the blood is the kind of shift that shows up as a result drifting rather than as anything alarming happening.
The direction is also worth noting, because it runs opposite to the enzyme story above. Enzyme inhibition raises levels; this particular observation is a fall. That is a reminder that interactions are specific to the pairing rather than general to the plant, which is exactly why the conversation is with somebody holding your own list.
It is also a reminder that absorption and metabolism are separate stages. A compound that slows the liver's clearance of a drug can still reduce how much of that drug gets in through the gut in the first place, and the two effects do not cancel neatly. Which one dominates is a property of the specific pairing and is measured rather than predicted.
Working out whether this concerns you
| Step | What it involves | How long it takes |
|---|---|---|
| List what you take | Everything, including anything bought over the counter | Five minutes |
| Find out which are cleared by CYP3A4 or CYP2D6 | Your pharmacist can answer this from the list without an appointment | One conversation |
| Name the plant, not the product | Say goldenseal, Hydrastis canadensis. A brand name means nothing to a prescriber | One sentence |
| Ask about timing and about whether to take it at all | Those are two different questions and both are worth asking | The same conversation |
| Write down the answer | So the same conversation is not needed again in six months | One minute |
Five steps. None requires an appointment with anyone, and the whole sequence is shorter than reading this article.
The second step is the one people skip, and it is the one that costs nothing. A pharmacist can look at a list of medicines and say which are cleared by the two enzymes named above, without an appointment and usually without a wait.
The third step is worth spelling out. Say goldenseal, or Hydrastis canadensis. A product name conveys nothing, and a description of the bottle conveys less.
- If nothing on your list goes through CYP3A4 or CYP2D6, this row is not your problem and you can stop thinking about it
- If something does, the question is whether to space the capsule from it or to skip the product entirely, and that is a judgement somebody with your list should make
- If you take metformin, mention it specifically, because it is the pairing with a published figure attached
- If you are unsure whether something counts as a medicine, include it; over-the-counter products are cleared by the same enzymes
What the carton says, and what it leaves out
The printed caution reads in full: Do not exceed recommended dose. Pregnant or nursing mothers, children under the age of 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement. Keep out of reach of children. Do not use if safety seal is damaged or missing.
It is a standard four-sentence set and it is not wrong. What it does not do is name a single thing specific to the eleven ingredients above it. No mention of goldenseal. No mention of calcium carbonate and thyroid medicine. No mention of the adsorbent clay at position ten.
That is ordinary for a dietary supplement carton and it is a real gap. A general caution asking anyone on medication to check with somebody is advice nobody acts on; naming the plant and the enzyme is advice somebody can do something with.
Supplying the specific version is most of what the safety page on this website is for, and it names three: this one, the calcium timing, and the clay.
References
- Chatterjee P, Franklin MR. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab Dispos. 2003;31(11):1391-7. PMID 14570772. https://pubmed.ncbi.nlm.nih.gov/14570772/
- Nguyen JT, Tian DD, Tanna RS, et al. An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based Pharmacokinetic Models to Understand Clinical Observations. J Pharmacol Exp Ther. 2023;387(3):252-264. PMID 37541764. https://pubmed.ncbi.nlm.nih.gov/37541764/
- Adiwidjaja J, Boddy AV, McLachlan AJ. Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib. Eur J Clin Pharmacol. 2022;78(4):597-611. PMID 35048143. https://pubmed.ncbi.nlm.nih.gov/35048143/
- Gurley BJ, Swain A, Barone GW, et al. Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos. 2007;35(2):240-5. PMID 17079360. https://pubmed.ncbi.nlm.nih.gov/17079360/
- McDonald MG, Tian DD, Thummel KE, et al. Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric Effects. Drug Metab Dispos. 2020;48(10):1018-1027. PMID 32591416. https://pubmed.ncbi.nlm.nih.gov/32591416/
- National Center for Complementary and Integrative Health. Goldenseal: Usefulness and Safety. Read 19 September 2026. States that there is not enough evidence to determine whether goldenseal is useful for any health condition, that study doses were about 3 g a day, that it should not be used in pregnancy or breastfeeding, and that metformin levels fell about 25% in healthy adults given goldenseal extract with metformin. https://www.nccih.nih.gov/health/goldenseal